Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Control of Liver Metastases With Intravenous Cetuximab and Hepatic Artery Infusion of Three-drug Chemotherapy in Patients With Liver-only Metastases From Colorectal Cancer. A European Multicenter Phase II Trial

NCT00852228 is registered in ClinicalTrials.gov with Association pour la Recherche sur le Temps Biologique et la Chronothérapie as lead sponsor.

NCT NCT00852228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00852228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Control of Liver Metastases With Intravenous Cetuximab and Hepatic Artery Infusion of Three-drug Chemotherapy in Patients With Liver-only Metastases From Colorectal Cancer. A European Multicenter Phase II Trial
Lead sponsor
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2008
Completion date
December 31, 2015
Enrollment
60 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic lesions, liver metastases, metastatic colorectal cancer